Deferoxamine mesylate
Term · Oncology and biomedicine · MLC-T-ONC-012947
The mesylate salt of an iron-chelating agent that binds free iron in a stable complex, preventing it from engaging in chemical reactions. Deferoxamine chelates iron from intra-lysosomal ferritin and ferrioxamine, a water-soluble complex excreted by the kidneys and in the feces via the bile. This agent does not readily chelate iron bound to transferrin, hemoglobin, myoglobin or cytochrome.
| Identifier | MLC-T-ONC-012947 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | DFM |
| Synonyms | deferoxamine methanesulfonate |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012947",
"term": "Deferoxamine mesylate",
"field": "Oncology and biomedicine",
"definition": "The mesylate salt of an iron-chelating agent that binds free iron in a stable complex, preventing it from engaging in chemical reactions. Deferoxamine chelates iron from intra-lysosomal ferritin and ferrioxamine, a water-soluble complex excreted by the kidneys and in the feces via the bile. This agent does not readily chelate iron bound to transferrin, hemoglobin, myoglobin or cytochrome.",
"abbreviation": "DFM",
"synonyms": [
"deferoxamine methanesulfonate"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/deferoxamine-mesylate/"
}
Record 5,768 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.